120 related articles for article (PubMed ID: 24573556)
1. Ubiquitin-like with PHD and ring finger domains 2 is a predictor of survival and a potential therapeutic target in colon cancer.
Lu S; Yan D; Wu Z; Jiang T; Chen J; Yuan L; Lin J; Peng Z; Tang H
Oncol Rep; 2014 Apr; 31(4):1802-10. PubMed ID: 24573556
[TBL] [Abstract][Full Text] [Related]
2. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer.
Zhou E; Huang Q; Wang J; Fang C; Yang L; Zhu M; Chen J; Chen L; Dong M
Int J Clin Exp Pathol; 2015; 8(7):8018-27. PubMed ID: 26339368
[TBL] [Abstract][Full Text] [Related]
4. Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer.
Li D; Peng X; Yan D; Tang H; Huang F; Yang Y; Peng Z
Ann Surg Oncol; 2011 Jul; 18(7):2074-83. PubMed ID: 21442350
[TBL] [Abstract][Full Text] [Related]
5. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
[TBL] [Abstract][Full Text] [Related]
6. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
[TBL] [Abstract][Full Text] [Related]
7. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of microRNA-93 downregulation in human colon cancer.
Xiao ZG; Deng ZS; Zhang YD; Zhang Y; Huang ZC
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):296-301. PubMed ID: 23354160
[TBL] [Abstract][Full Text] [Related]
9. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
11. High NUSAP1 expression predicts poor prognosis in colon cancer.
Liu Z; Guan C; Lu C; Liu Y; Ni R; Xiao M; Bian Z
Pathol Res Pract; 2018 Jul; 214(7):968-973. PubMed ID: 29853313
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of eIF3e is correlated with colon tumor development and poor prognosis.
Li Z; Lin S; Jiang T; Wang J; Lu H; Tang H; Teng M; Fan J
Int J Clin Exp Pathol; 2014; 7(10):6462-74. PubMed ID: 25400724
[TBL] [Abstract][Full Text] [Related]
13. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery.
Yan DW; Li DW; Yang YX; Xia J; Wang XL; Zhou CZ; Fan JW; Wen YG; Sun HC; Wang Q; Qiu GQ; Tang HM; Peng ZH
Br J Cancer; 2010 Sep; 103(7):961-9. PubMed ID: 20808312
[TBL] [Abstract][Full Text] [Related]
15. COLORECTAL Polymeric Immunoglobulin Receptor Expression is Correlated with Hepatic Metastasis and Poor Prognosis in Colon Carcinoma Patients with Hepatic Metastasis.
Liu F; Ye P; Bi T; Teng L; Xiang C; Wang H; Li Y; Jin K; Mou X
Hepatogastroenterology; 2014 May; 61(131):652-9. PubMed ID: 26176052
[TBL] [Abstract][Full Text] [Related]
16. UHRF2 decreases H3K9ac expression by interacting with it through the PHD and SRA/YDG domain in HepG2 hepatocellular carcinoma cells.
Zhang T; Zhao L; Zeng S; Bai L; Chen J; Zhang Z; Wang Y; Duan C
Int J Mol Med; 2017 Jan; 39(1):126-134. PubMed ID: 28004105
[TBL] [Abstract][Full Text] [Related]
17. Developmental pluripotency-associated 4: a novel predictor for prognosis and a potential therapeutic target for colon cancer.
Zhang M; Cui F; Lu S; Lu H; Xue Y; Wang J; Chen J; Zhao S; Ma S; Zhang Y; Yu Y; Peng Z; Tang H
J Exp Clin Cancer Res; 2015 Jun; 34(1):60. PubMed ID: 26063247
[TBL] [Abstract][Full Text] [Related]
18. Expression status of cyclase‑associated protein 2 as a prognostic marker for human breast cancer.
Xu L; Peng S; Huang Q; Liu Y; Jiang H; Li X; Wang J
Oncol Rep; 2016 Oct; 36(4):1981-8. PubMed ID: 27573674
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance and prognostic value of Nek2 protein expression in colon cancer.
Lu L; Zhai X; Yuan R
Int J Clin Exp Pathol; 2015; 8(11):15467-73. PubMed ID: 26823916
[TBL] [Abstract][Full Text] [Related]
20. Period 1 and estrogen receptor-beta are downregulated in Chinese colon cancers.
Wang Y; Xing T; Huang L; Song G; Sun X; Zhong L; Fan J; Yan D; Zhou C; Cui F; Yu F; Chen J; Yu Y; Li C; Tang H; Peng Z; Wang X
Int J Clin Exp Pathol; 2015; 8(7):8178-88. PubMed ID: 26339386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
